Special Considerations and Clinical Management of HIV-Infected Drug Users

  • Author: Frederick L. Altice, MD (More Info)
  • Editors in Chief: Daniel R. Kuritzkes, MD; Joseph J. Eron, Jr., MD
  • Last Reviewed: 4/1/16 (What's New)

Summary

  • IAPAC guidelines on improving entry into and retention in care in people with HIV infection include the following recommendations regarding substance users (Management Guidelines)[Thompson 2012]:
    • Buprenorphine or methadone should be provided to opioid-dependent patients
    • Provision of DAART for HIV-infected PWIDs if resources available

Action required

Keywords: Adherence, Correctional Settings, Initial Antiretroviral Therapy, IV Drug Use, Psychiatric Disorders, Psychosocial Issues, Quality of Life, Resource-Limited Settings, Special Populations, Treatment Complications

©2018 Clinical Care Options, LLC. All Rights Reserved.

The materials published via inPractice® reflect the views of the reviewers or authors of the material, not those of Clinical Care Options, LLC, the accredited provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.